Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
2.900
0.00 (0.00%)
At close: Sep 18, 2024, 4:00 PM
2.970
+0.070 (2.41%)
After-hours: Sep 18, 2024, 7:52 PM EDT

Xeris Biopharma Holdings Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for XERS stock have an average target of 4.67, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 61.03% from the current stock price of 2.90.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $4.67 $5.00 $6.00
Change +3.45% +61.03% +72.41% +106.90%
* Price targets were last updated on Aug 15, 2024.

Analyst Ratings

The average analyst rating for XERS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 222221
Buy 222222
Hold 000000
Sell 000000
Strong Sell 000000
Total 444443

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +106.90% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +106.90% May 31, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$4$3
Buy Reiterates $4$3 +3.45% May 10, 2024
Oppenheimer
Oppenheimer
Buy
Initiates
$5
Buy Initiates $5 +72.41% Mar 28, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5.5$6
Strong Buy Maintains $5.5$6 +106.90% Mar 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
197.27M
from 163.91M
Increased by 20.35%
Revenue Next Year
229.11M
from 197.27M
Increased by 16.14%
EPS This Year
-0.41
from -0.45
EPS Next Year
-0.25
from -0.41
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
2.72M20.44M49.59M110.25M163.91M197.27M229.11M272.76M
Revenue Growth
12.34%650.73%142.67%122.32%48.68%20.35%16.14%19.05%
EPS
-4.81-2.14-1.55-0.70-0.45-0.41-0.250.07
EPS Growth
--------
Forward PE
-------44.42
No. Analysts -----887
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 204.5M 250.9M 305.3M
Avg 197.3M 229.1M 272.8M
Low 187.6M 196.1M 240.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
24.8%
27.2%
33.3%
Avg
20.3%
16.1%
19.1%
Low
14.4%
-0.6%
4.8%

EPS Forecast

EPS 20242025202620272028
High -0.37 -0.09 0.21
Avg -0.41 -0.25 0.07
Low -0.42 -0.39 -0.05

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.